Insulin Resistance in Gastroesophageal Reflux Disease
Abstract
Keywords
References
Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26:19-39.
Huang P. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5-6):231-7.
Badan Penelitian dan Pengembangan Kesehatan RI. Riset Kesehatan Dasar (Riskesdas). Jakarta:2013.
Soewondo P, Purnamasari D, Oemardi M, et al. Prevalence of metabolic syndrome using NCEP/ATP III criteria in Jakarta, Indonesia. The Jakarta primary noncommunicable disease risk factors surveillance 2006. Acta Med Indones. 2010:42 (4):199-203.
The Indonesian Society of Gastroenterology. National consensus on the management of gastroesophageal reflux disease in Indonesia. Acta Med Indones. 2014;46(3):263-71.
Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5(3):105-12.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–28.
Morino K, Petersen KF, Shulman GI. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes. 2006;55(Suppl.2):S9-S15.
Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes. 2010;1(3):68-75.
Abel ED, O’Shea KM, Ramasamy R. Insulin resistance: metabolic mechanisms and consequences in the Heart. Arterioscler Thromb Vasc Biol. 2012;32:2068-76.
Masharani U, German M. Pancreatic hormones and diabetes mellitus. Greenspan’s basic and clinical endocrinology. 9th ed. New York: McGraw-Hill; 2011. p. 590-2.
Borai A, Livingstone C, Kaddam I, Ferns G. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Method. 2011;11:158.
Wallace T, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Dia Care. 2004;27(6):1487-95.
Yamada C, Moriyama C, Takahashi E. Optimal cut-off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non-diabetic Japanese subjects. J Diabetes Invest. 2012;3(4):384-7.
Gosal F, Waleleng BJ, Pandelaki K. Hubungan kadar TNF α, nilai HOMA-IR dan pelemakan hati sederhana nonalkoholik pada pelajar SMA dengan obesitas. J Indon Med Assoc. 2013;63(1)27-31.
Nasution IR, Setiati S, Trisnohadi HB, Oemardi M. Insulin resistance and metabolic syndrome in elderly women living in nursing homes. Acta Med Indones. 2006;38(1):1-6.
Sun X, Tan J, Zhu Y, Lin L. Association between diabetes mellitus and gastroesophageal reflux disease: A meta-analysis. World J Gastroenterol. 2015;21(10): 3085-92.
Abdullah M, Makmun D, Syam AF, et al. Prevalence, risk factors and socio-epidemiological study of gastroesophageal reflux disease: An urban population based study in Indonesia. Asian J Epidemiol. 2016;9(1-3):18-23.
Syam AF, Hapsari F, Makmun D. The prevalence and risk factors of GERD among Indonesian medical doctors. Makara J Health Res. 2016;20(2):35-40.
Nwokediuko SC. Current trends in the management of gastroesophageal reflux disease: A review. ISRN Gastroenterol. 2013:1-11.
Herbella F, Patti MG. Gastroesophageal reflux disease: From pathophysiology to Treatment. World J Gastroenterol. 2010;16(30):3745-9.
Park JH, Park DI, Kim HJ, et al. Metabolic syndrome is associated with erosive esophagitis. World J Gastroenterol. 2008;14(35):5442-7.
Wu P, Ma L, Dai GX, et al. The association of metabolic syndrome with reflux esophagitis: a case-control study. Neurogastroenterol Motility. 2011;23(11):989-94.
Punjabi P, Hira A, Prasad S, et al. Review of gastroesophageal reflux disease (GERD) in the diabetic patient. Journal of Diabetes 2015; 7:599–609.
Lee SD, Keum B, Chun HJ, Bak YT. Gastroesophageal reflux disease in type II diabetes mellitus with or without peripheral neuropathy. J Neurogastroenterol Motil. 2011;17:274-8.
Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013;4 (3):51-63.
Rayner CK, Samsom M, Jones K, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diab Care. 2001;24(2):371-81.
The American Association of Clinical Endocrinologists. AACE Position Statement on the Insulin Resistance syndrome. Endocr Pract. 2003:9(3):240-9.
Nam SY, Choi IJ, Ryu KH, et al. The effect of abdominal visceral fat, circulating inflammatory cytokines and leptin levels on reflux esophagitis. J Neurogastroenterol Motil. 2015;21(2):247-52.
Rieder F, Biancani P, Hatnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010;298(5):G571–G81.
Ming Tai C, Chia Lee Y, Pin Tu H, et al. The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese chinese patients. Obesity. 2010;18:2165–9.
Caro SD, Cheung WH, Fini L, et al. Role of body composition and metabolic profile in Barrett’s oesophagus and progression to cancer. Eur J Gastroenterol Hepatol. 2016;28(3):251–60.
Hsu CS, Wang PC, Chen JH, et al. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:994-1004.
Pointer SD, Ricktrew J, Slaughter JC, et al. Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in european-and african-american obese women. Aliment Pharmacol Ther. 2016;44:976–88.
Fujiwara M, Eguchi Y, Fukomori N, et al. The symptoms of gastroesophageal reflux disease correlate with high body mass index, the aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease. Intern Med. 2015;54:3099-104.
Ivashkin V, Evzyustina Y, Trukhmanoz, et al. Systemic inflammatory response in patients with gastroesophageal reflux disease. Am J Clin Med Res. 2015;3(4):64-9.
Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension. 2005;45:828-33.
Fernandez JM, Vayreda M, Richart C, et al. Circulating interleukin 6 levels, blood pressure and insulin sensitivity in apparently healthy men and woman. J CLin Endocrinol Metab. 2001;86:1154-9.
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-8.
Refbacks
- There are currently no refbacks.